Yield10 Bioscience Inc (OTCPK:YTEN)
$ 1.05 0 (0%) Market Cap: 690,000.00 Enterprise Value: 2.75 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 40/100

Q4 2021 Yield10 Bioscience Inc Earnings Call Transcript

Mar 09, 2022 / 09:30PM GMT
Release Date Price: $111.12 (+6.93%)
Operator

Welcome to the Fourth Quarter and Full Year 2021 Financial Results and Business Update Conference Call for Yield10 Bioscience. (Operator Instructions) As a reminder, this conference call is being recorded.

I would now like to turn the conference call over to your host, Yield10 Vice President of Planning and Corporate Communications, Lynne Brum.

Lynne H. Brum
Yield10 Bioscience, Inc. - VP of Planning & Corporate Communications and Secretary

Thank you, Alex, and good afternoon, everyone. Welcome to Yield10 Bioscience Fourth Quarter and Full Year 2021 Conference Call. Joining me on the call today are President and CEO, Dr. Oliver Peoples; Vice President of Research and Chief Science Officer, Dr. Kristi Snell; and Chief Accounting Officer, Chuck Haaser.

Earlier this afternoon, Yield10 issued our fourth quarter and full year 2021 financial results. This press release as well as slides accompany today's presentation are available on the Investor Relations Events section of our website at yield10bio.com.

Let's turn to Slide 2. Please

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot